<DOC>
	<DOCNO>NCT00392652</DOCNO>
	<brief_summary>This randomized phase I trial study side effect best dose diindolylmethane healthy volunteer . Chemoprevention use certain drug substance keep cancer forming , grow , come back . The use diindolylmethane may keep cancer form . Collecting store sample blood urine healthy volunteer study laboratory may help doctor learn way person 's body handle drug .</brief_summary>
	<brief_title>Diindolylmethane Healthy Volunteers</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine effect multiple daily dose nutritional-grade , absorption-enhanced diindolylmethane ( BR-DIM ) disposition probe drug metabolize cytochrome P4501A2 ( CYP1A2 ) CYP3A4 healthy volunteer . SECONDARY OBJECTIVES : I . Determine effect multiple daily dose BR-DIM estrogen metabolite urine activity CYP2C9 , CYP2D6 , P-glycoprotein/OATP . II . Determine effect single dose BR-DIM disposition probe drug metabolize transported CYP1A2 , CYP2C9 , CYP2D6 , CYP3A4 , P-glycoprotein ( P-go ) . III . Determine safety tolerability single multiple daily dose BR-DIM . IV . Determine pharmacokinetics single dose BR-DIM dose chronic daily dosing . V. Determine pharmacokinetics single dose BR-DIM dose chronic daily dosing . TERTIARY OBJECTIVES : I . To determine effect BR-DIM activity glutathione-S-transferase ( GST ) , phase 2 enzyme , lymphocytes . OUTLINE : This randomize , double-blind study . Participants stratify accord gender . Participants randomize 1 2 intervention arm . Arm I : Participants receive low-dose oral diindolylmethane ( BR-DIM ) twice daily 4 week . Arm II : Participants receive high-dose oral BR-DIM twice daily 4 week . In arm , participant receive oral probe-drug cocktail comprise caffeine ( CYP1A2 ) , dextromethorphan ( CYP2D6 ) , buspirone ( CYP3A4 ) , losartan ( CYP2C9 ) , fexofenadine ( P-glycoprotein ) randomization first last dose BR-DIM . Blood urine collect periodically pharmacokinetic profile BR-DIM probe drug . After completion study intervention , participant follow 1 week .</detailed_description>
	<criteria>Criteria : Healthy men woman Nonsmoker confirm urine cotinine test No active malignancy Life expectancy &gt; = 12 month Hemoglobin &gt; 10 g/dL Absolute granulocyte count &gt; 1,500/mm^3 Creatinine &lt; 2.0 mg/dL Albumin &gt; 3.0 g/dL Bilirubin &lt; 1.8 mg/dL AST ALT &lt; 110 U/L Alkaline phosphatase &lt; 300 U/L Body mass index = &lt; 30 Not pregnant nursing Negative pregnancy test Fertile participant must use effective nonhormonal contraception No acute , unstable , chronic , recur medical condition No strict vegetarian consumption &gt; 3 medium serving ( 1/2 cup ) cruciferous vegetable per week Participants stop eat cruciferous vegetable within past 2 week agree refrain eat duration study eligible Cruciferous vegetable include broccoli , cabbage ( include coleslaw ) , cauliflower , bokchoy , brussels sprout , collard , kale , kohlrabi , mustard green , rutabaga , turnip , watercress No serious drug allergy serious intolerance allergy Mild seasonal allergy allow No chronic condition , include headache , dysphoria , fatigue , dizziness , blur vision , insomnia , rhinorrhea , nausea , vomit , abdominal pain , diarrhea , constipation , menopausal hot flashes/night sweat , clinically significant premenstrual syndrome No serious acute chronic illness No requirement chronic drug therapy No alcohol ingestion within 48 hour study treatment No investigational drug within past 3 month No prior chemotherapy No concurrent regular medication hormones No recent change medication dosage medication No concurrent regular supplement vitamins No concurrent overthecounter medication No concurrent grapefruit juice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>